 Steven Coultrap
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 25 | 2023 | 159 | 5.170 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 19 | 2020 | 191 | 1.550 |
Why?
| | Long-Term Potentiation | 13 | 2023 | 148 | 1.290 |
Why?
| | Calcium | 7 | 2023 | 1169 | 1.100 |
Why?
| | Hippocampus | 20 | 2023 | 735 | 1.060 |
Why?
| | Long-Term Synaptic Depression | 5 | 2017 | 51 | 0.940 |
Why?
| | Phosphorylation | 25 | 2023 | 1633 | 0.900 |
Why?
| | Neurons | 13 | 2021 | 1345 | 0.780 |
Why?
| | Synapses | 7 | 2023 | 344 | 0.750 |
Why?
| | Calmodulin | 5 | 2014 | 73 | 0.690 |
Why?
| | Nitric Oxide | 2 | 2014 | 892 | 0.680 |
Why?
| | Memory | 4 | 2017 | 230 | 0.610 |
Why?
| | Second Messenger Systems | 1 | 2014 | 31 | 0.500 |
Why?
| | HEK293 Cells | 6 | 2020 | 625 | 0.390 |
Why?
| | Synaptic Transmission | 2 | 2012 | 239 | 0.390 |
Why?
| | Protein Kinase Inhibitors | 5 | 2018 | 811 | 0.390 |
Why?
| | Drug Design | 1 | 2011 | 160 | 0.380 |
Why?
| | Glutamic Acid | 6 | 2023 | 224 | 0.380 |
Why?
| | Amino Acid Sequence | 6 | 2017 | 2071 | 0.380 |
Why?
| | Rats | 22 | 2018 | 5392 | 0.350 |
Why?
| | Molecular Sequence Data | 6 | 2014 | 2871 | 0.340 |
Why?
| | Peptides | 2 | 2011 | 879 | 0.340 |
Why?
| | Death-Associated Protein Kinases | 2 | 2020 | 10 | 0.340 |
Why?
| | Receptors, AMPA | 5 | 2018 | 125 | 0.330 |
Why?
| | Brain Ischemia | 1 | 2011 | 310 | 0.310 |
Why?
| | Substrate Specificity | 3 | 2014 | 371 | 0.300 |
Why?
| | Animals | 33 | 2023 | 33381 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 15 | 2020 | 2478 | 0.280 |
Why?
| | Heart Arrest | 2 | 2020 | 291 | 0.250 |
Why?
| | Brain | 2 | 2018 | 2490 | 0.240 |
Why?
| | Alternative Splicing | 1 | 2005 | 193 | 0.230 |
Why?
| | Neuroprotective Agents | 3 | 2020 | 111 | 0.220 |
Why?
| | Receptors, Serotonin | 2 | 1999 | 33 | 0.220 |
Why?
| | Isoenzymes | 2 | 2014 | 297 | 0.220 |
Why?
| | Holoenzymes | 2 | 2021 | 21 | 0.210 |
Why?
| | Ethanol | 4 | 2011 | 575 | 0.210 |
Why?
| | Cell Death | 4 | 2020 | 339 | 0.200 |
Why?
| | Gene Expression Regulation | 4 | 2010 | 2445 | 0.200 |
Why?
| | Neuroprotection | 2 | 2020 | 31 | 0.190 |
Why?
| | Protein Binding | 6 | 2023 | 1975 | 0.190 |
Why?
| | Models, Molecular | 3 | 2017 | 1435 | 0.180 |
Why?
| | Maleimides | 1 | 1999 | 23 | 0.180 |
Why?
| | Serotonin Antagonists | 1 | 1999 | 31 | 0.180 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2011 | 175 | 0.170 |
Why?
| | Protein Kinase C | 2 | 2002 | 297 | 0.160 |
Why?
| | Lipoylation | 1 | 2017 | 16 | 0.160 |
Why?
| | Ischemia | 2 | 2020 | 374 | 0.160 |
Why?
| | Protein Conformation | 3 | 2021 | 848 | 0.160 |
Why?
| | Enzyme Inhibitors | 3 | 2005 | 827 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 408 | 0.160 |
Why?
| | Peptide Fragments | 3 | 2018 | 702 | 0.150 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2018 | 290 | 0.150 |
Why?
| | Synaptic Membranes | 2 | 2008 | 18 | 0.150 |
Why?
| | Mice | 10 | 2023 | 15520 | 0.150 |
Why?
| | In Vitro Techniques | 8 | 2010 | 1094 | 0.150 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 72 | 0.150 |
Why?
| | Mutation | 4 | 2020 | 3457 | 0.150 |
Why?
| | Protein Tyrosine Phosphatases | 4 | 2012 | 145 | 0.150 |
Why?
| | Indoles | 1 | 1999 | 316 | 0.150 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2014 | 39 | 0.140 |
Why?
| | Spine | 1 | 2017 | 144 | 0.140 |
Why?
| | Amyloid beta-Peptides | 1 | 2018 | 200 | 0.140 |
Why?
| | Neuronal Plasticity | 4 | 2023 | 219 | 0.130 |
Why?
| | Central Nervous System Depressants | 2 | 2010 | 89 | 0.130 |
Why?
| | Adenosine Triphosphate | 3 | 2013 | 439 | 0.120 |
Why?
| | Phosphoserine | 1 | 2014 | 34 | 0.120 |
Why?
| | Cell Line | 3 | 2011 | 2707 | 0.120 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2014 | 105 | 0.120 |
Why?
| | Neural Inhibition | 2 | 2012 | 160 | 0.120 |
Why?
| | Tyrosine | 2 | 2005 | 233 | 0.120 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 285 | 0.110 |
Why?
| | Subcellular Fractions | 3 | 2007 | 84 | 0.110 |
Why?
| | Protein Subunits | 3 | 2013 | 211 | 0.110 |
Why?
| | Protein Transport | 5 | 2018 | 412 | 0.110 |
Why?
| | Humans | 15 | 2020 | 118974 | 0.110 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 136 | 0.110 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 823 | 0.100 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2011 | 2 | 0.100 |
Why?
| | Enzyme Activation | 4 | 2017 | 828 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 940 | 0.100 |
Why?
| | Alanine | 1 | 2011 | 102 | 0.100 |
Why?
| | Pyramidal Cells | 2 | 2010 | 54 | 0.100 |
Why?
| | Solutions | 1 | 2011 | 156 | 0.100 |
Why?
| | Serine | 1 | 2011 | 138 | 0.100 |
Why?
| | Mutagenesis | 1 | 2011 | 176 | 0.100 |
Why?
| | Nucleotides | 1 | 2011 | 112 | 0.100 |
Why?
| | Blotting, Western | 4 | 2007 | 1194 | 0.090 |
Why?
| | PC12 Cells | 1 | 2010 | 40 | 0.090 |
Why?
| | Autophagy | 1 | 2014 | 315 | 0.090 |
Why?
| | Corpus Striatum | 1 | 2011 | 127 | 0.090 |
Why?
| | Signal Transduction | 3 | 2014 | 4709 | 0.090 |
Why?
| | Kinetics | 2 | 2011 | 1624 | 0.090 |
Why?
| | Transfection | 2 | 2017 | 888 | 0.090 |
Why?
| | Patch-Clamp Techniques | 3 | 2010 | 247 | 0.090 |
Why?
| | Dendritic Spines | 2 | 2020 | 52 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 502 | 0.080 |
Why?
| | Staurosporine | 2 | 2013 | 23 | 0.070 |
Why?
| | Benzylamines | 3 | 2010 | 40 | 0.070 |
Why?
| | Protein Domains | 2 | 2018 | 212 | 0.070 |
Why?
| | Male | 15 | 2021 | 57801 | 0.070 |
Why?
| | Septum of Brain | 1 | 2005 | 3 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 4908 | 0.070 |
Why?
| | Cholinergic Fibers | 1 | 2005 | 19 | 0.070 |
Why?
| | Nerve Growth Factor | 1 | 2005 | 29 | 0.070 |
Why?
| | Synapsins | 1 | 2005 | 13 | 0.070 |
Why?
| | Actinin | 1 | 2005 | 14 | 0.070 |
Why?
| | Nerve Net | 1 | 2007 | 232 | 0.060 |
Why?
| | Animals, Newborn | 3 | 2014 | 806 | 0.060 |
Why?
| | Seizures | 1 | 2007 | 345 | 0.060 |
Why?
| | Thiazolidinediones | 1 | 2004 | 146 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2018 | 4077 | 0.060 |
Why?
| | Excitatory Amino Acid Antagonists | 3 | 2010 | 90 | 0.060 |
Why?
| | Receptors, Serotonin, 5-HT3 | 2 | 1999 | 17 | 0.050 |
Why?
| | Optogenetics | 1 | 2023 | 96 | 0.050 |
Why?
| | Xenopus laevis | 2 | 1999 | 128 | 0.050 |
Why?
| | Fear | 1 | 2004 | 307 | 0.050 |
Why?
| | Single Molecule Imaging | 1 | 2021 | 35 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 551 | 0.050 |
Why?
| | Neurotoxins | 1 | 2020 | 27 | 0.050 |
Why?
| | Phenanthridines | 1 | 1999 | 6 | 0.040 |
Why?
| | Benzophenanthridines | 1 | 1999 | 10 | 0.040 |
Why?
| | Alkaloids | 1 | 1999 | 23 | 0.040 |
Why?
| | 2-Amino-5-phosphonovalerate | 2 | 2010 | 11 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 1224 | 0.040 |
Why?
| | Learning | 1 | 2023 | 374 | 0.040 |
Why?
| | Naphthalenes | 1 | 1999 | 41 | 0.040 |
Why?
| | Binding, Competitive | 1 | 1999 | 205 | 0.040 |
Why?
| | Cell Membrane | 2 | 2002 | 710 | 0.040 |
Why?
| | Oocytes | 1 | 1999 | 190 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2018 | 55 | 0.040 |
Why?
| | Electric Stimulation | 2 | 2010 | 268 | 0.040 |
Why?
| | Resuscitation | 1 | 2020 | 253 | 0.040 |
Why?
| | Exons | 1 | 2018 | 307 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2018 | 345 | 0.040 |
Why?
| | Sulfonamides | 2 | 2010 | 445 | 0.040 |
Why?
| | Microscopy, Electron | 1 | 2017 | 413 | 0.040 |
Why?
| | Disks Large Homolog 4 Protein | 2 | 2007 | 18 | 0.040 |
Why?
| | Protein Multimerization | 1 | 2017 | 161 | 0.030 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2017 | 183 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 2005 | 245 | 0.030 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 9 | 0.030 |
Why?
| | Electrophysiology | 2 | 2007 | 204 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 1945 | 0.030 |
Why?
| | Aging | 1 | 2004 | 1670 | 0.030 |
Why?
| | Pepstatins | 1 | 2014 | 5 | 0.030 |
Why?
| | Sequestosome-1 Protein | 1 | 2014 | 18 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2007 | 1293 | 0.030 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 67 | 0.030 |
Why?
| | Muramidase | 1 | 2014 | 72 | 0.030 |
Why?
| | Cross-Linking Reagents | 2 | 2007 | 186 | 0.030 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 29 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2007 | 404 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 270 | 0.030 |
Why?
| | Female | 5 | 2021 | 61565 | 0.030 |
Why?
| | Adenosine Diphosphate | 1 | 2013 | 88 | 0.030 |
Why?
| | Leucine | 1 | 2014 | 117 | 0.030 |
Why?
| | Point Mutation | 1 | 2014 | 228 | 0.030 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 129 | 0.030 |
Why?
| | Protease Inhibitors | 1 | 2014 | 102 | 0.030 |
Why?
| | RNA | 1 | 1999 | 833 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 403 | 0.030 |
Why?
| | Memantine | 1 | 2012 | 18 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2018 | 513 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 188 | 0.030 |
Why?
| | N-Methylaspartate | 1 | 2012 | 38 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 395 | 0.030 |
Why?
| | DNA | 1 | 1999 | 1388 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2014 | 300 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 460 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2007 | 1691 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 564 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2012 | 89 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 5691 | 0.030 |
Why?
| | Caspase 3 | 1 | 2012 | 243 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 382 | 0.020 |
Why?
| | Action Potentials | 1 | 2014 | 420 | 0.020 |
Why?
| | Bicuculline | 1 | 2010 | 21 | 0.020 |
Why?
| | Phosphinic Acids | 1 | 2010 | 9 | 0.020 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2010 | 16 | 0.020 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 20 | 0.020 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 18 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2657 | 0.020 |
Why?
| | Gene Products, tat | 1 | 2010 | 21 | 0.020 |
Why?
| | Membrane Proteins | 2 | 2007 | 1055 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2010 | 89 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2010 | 307 | 0.020 |
Why?
| | Microdissection | 1 | 2008 | 13 | 0.020 |
Why?
| | Propionates | 1 | 2007 | 35 | 0.020 |
Why?
| | Mossy Fibers, Hippocampal | 1 | 2007 | 7 | 0.020 |
Why?
| | Kainic Acid | 1 | 2007 | 32 | 0.020 |
Why?
| | Threonine | 1 | 2007 | 45 | 0.020 |
Why?
| | Biphenyl Compounds | 1 | 2007 | 52 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 653 | 0.020 |
Why?
| | Maze Learning | 1 | 2007 | 86 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2010 | 486 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2010 | 416 | 0.020 |
Why?
| | Dendrites | 1 | 2007 | 88 | 0.020 |
Why?
| | Calnexin | 1 | 2005 | 3 | 0.020 |
Why?
| | Phenanthrolines | 1 | 2005 | 8 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2010 | 726 | 0.020 |
Why?
| | Mental Recall | 1 | 2007 | 180 | 0.020 |
Why?
| | Receptor, trkA | 1 | 2005 | 20 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2005 | 161 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2005 | 149 | 0.020 |
Why?
| | Phenols | 1 | 2005 | 85 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2005 | 88 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2010 | 601 | 0.020 |
Why?
| | Precipitin Tests | 1 | 2003 | 93 | 0.010 |
Why?
| | Cell Fractionation | 1 | 2002 | 53 | 0.010 |
Why?
| | Chymotrypsin | 1 | 2002 | 21 | 0.010 |
Why?
| | Stroke | 1 | 2010 | 1047 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2002 | 90 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2005 | 709 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 1541 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1715 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6412 | 0.010 |
Why?
| | Age Factors | 1 | 2005 | 2995 | 0.010 |
Why?
|
|
Coultrap's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|